Original research article| Volume 99, ISSUE 4, P233-238, April 2019

Patient recommendations for PrEP information dissemination at family planning clinics in Atlanta, Georgia



      Family planning (FP) clinics are an ideal setting to disseminate information about pre-exposure prophylaxis (PrEP), but little is known about women's preferences for learning about PrEP in this setting.

      Study design

      We surveyed 500 women seeking care at 4 FP clinics in Atlanta. Before their provider visit, participants completed an HIV-risk screener. After, we asked participants about the HIV prevention counseling they received and how clinics could share information about PrEP. We performed descriptive analyses on demographics, HIV risk, and PrEP awareness/interest, and conducted thematic analysis on open-ended responses.


      Only 18% knew about PrEP before the study; 28% of 376 sexually-active women had≥1 risk indicator consistent with PrEP eligibility. Three hundred forty seven women (69%) shared suggestions about how clinics should share PrEP information. We categorized suggestions into 4 themes - Advertising, Conversations, Awareness and Access. Participants (n=150) suggested clinics should advertise PrEP via brochures, posters, texts, or emails; 134 wanted providers to talk to patients about PrEP. Several (n=71) suggested sharing PrEP information broadly in the community and with other clinics/providers; others (n=11) wanted improved access to PrEP services.


      Our results demonstrate overwhelming patient interest in learning more about PrEP through educational materials and directly from FP providers. Women were vocal about increasing PrEP awareness in the community, particularly among populations especially at risk for HIV (e.g., teens). These suggestions can be translated into actionable steps FP clinics can take to increase PrEP awareness and expand their reach to benefit women at risk for HIV.


      High HIV rates among women in the South make it imperative to increase awareness of PrEP among women. Atlanta women seeking care in FP clinics valued learning about PrEP and recommended feasible strategies for disseminating information about PrEP in community settings, the clinic or during patient-provider discussion.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hess K.
        • Hu X.
        • Lansky A.
        • Mermin J.
        • Hall H.I.
        Estimating the lifetime risk of a diagnosis of HIV infection in the United States.
        in: Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 22–25; Abstract #52, And CDC press release. 2016 (Available at:)
        • Centers for Disease Control and Prevention (CDC)
        Diagnoses of HIV infection in the United States and dependent areas, 2016.
        in: HIV Surveillance Report. 2017: 28
        • Centers for Disease Control and Prevention (CDC)
        CDC Issue Brief: HIV in the southern United States.
        (Updated May 2016. Available at:)
        • Centers for Disease Control and Prevention (CDC)
        Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention.
        (Available at:)
        • Chen Y.H.
        • Raymond H.F.
        • McFarland W.
        • Truong H.H.
        HIV risk behaviors in heterosexual partnerships: female knowledge and male behavior.
        AIDS Behav. 2010; 14: 87-91
        • Food and Drug Administration (FDA)
        FDA approves first drug for reducing the risk of sexually acquired HIV infection.
        ([Washington, DC])2012
        • Sheth A.N.
        • Rolle C.P.
        • Gandhi M.
        HIV pre-exposure prophylaxis for women.
        J Virus Erad. 2016; 2: 149
        • Smith D.K.
        • Van Handel M.
        • Grey J.
        Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015.
        Ann Epidemiol. 2018; 28: 850-857
        • Siegler A.J.
        • Mouhanna F.
        • Giler R.M.
        • McCallister S.
        • Yeung H.
        • Jones J.
        Distribution of active PrEP prescriptions and the PrEP-to-need ratio, US, Q2 2017.
        in: 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018), Boston, Abstract 1022LB. 2018
      1. US Dept of Health and Human Services Program announcement number PAR-10-038.
        (Available at:)
        • Young I.
        • McDaid L.
        How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention.
        AIDS Behav. 2014; 18: 195-216
        • Edelstein Z.
        • Mensah N.
        • Scanlin K.
        • Cutler B.
        • Myers J.
        Awareness of HIV prevention innovations among women of color in NYC: HIV self-tests and pre-exposure prophylaxis (PrEP).
        in: 142nd APHA Annual Meeting and Exposition (November 15–November 19, 2014). 2014
        • Auerbach J.D.
        • Kinsky S.
        • Brown G.
        • Charles V.
        Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.
        AIDS Patient Care STDS. 2015; 29: 102-110
        • Doblecki-Lewis S.
        • Lester L.
        • Schwartz B.
        • Collins C.
        • Johnson R.
        • Kobetz E.
        HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami.
        Int J STD AIDS. 2016; 27: 873-881
        • Walters S.M.
        • Reilly K.H.
        • Neaigus A.
        • Braunstein S.
        Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.
        Harm Reduct J. 2017; 14: 40
        • Collier K.L.
        • Colarossi L.G.
        • Sanders K.
        Raising awareness of pre-exposure prophylaxis (PrEP) among women in new York City: community and provider perspectives.
        J Health Commun. 2017 Mar 4; 22: 183-189
        • Gavin L.
        • Pazol K.
        Update: Providing quality FP services — Recommendations from CDC and the U.S. Office of Population Affairs, 2015.
        MMWR Morb Mortal Wkly Rep. 2016; 65 ([PMID: 26963363]): 231-234
        • Office of Population Affairs
        HIV Prevention in FP.
        (Available at:)
      2. US women & PrEP working group position statement.
        • Seidman D.
        • Weber S.
        • Carlson K.
        • Witt J.
        Family planning providers' role in offering PrEP to women.
        Contraception. 2018; 97: 467-470
        • Seidman D.
        • Weber S.
        Integrating preexposure prophylaxis for human immunodeficiency virus prevention into women's health care in the United States.
        Obstet Gynecol. 2016; 128: 37-43
        • Pollock L.
        • Levison J.
        Role of Preexposure prophylaxis in the reproductive health of women at risk for human immunodeficiency virus infection.
        Obstet Gynecol. 2018; 132: 687-691
        • Aaron E.
        • Blum C.
        • Seidman D.
        • Hoyt M.J.
        • Simone J.
        • Sullivan M.
        • et al.
        Optimizing delivery of HIV Preexposure prophylaxis for women in the United States.
        AIDS Patient Care STDS. 2018; 32: 16-23
        • Seidman D.
        • Carlson K.
        • Weber S.
        • Witt J.
        • Kelly P.J.
        United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
        Contraception. 2016; 93: 463-469
        • Tripathi A.
        • Whiteside O.
        • Scanlon C.
        • Duffus W.
        Perceptions and attitudes about PrEP among seronegative partners and the potential of sexual disinhibition associated with the use of PrEP.
        J Int AIDS Soc. 2012; 15: 108-109
        • Koren D.E.
        • Nichols J.S.
        • Simoncini G.M.
        HIV pre-exposure prophylaxis and women: survey of the knowledge, attitudes, and beliefs in an urban obstetrics/gynecology clinic.
        AIDS Patient Care STDS. 2018; 32: 490-494
        • Garfinkel D.B.
        • Alexander K.A.
        • McDonald-Mosley R.
        • Willie T.C.
        • Decker M.R.
        Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients.
        AIDS Care. 2017; 29: 751-758
        • US Public Health Service
        Preexposure prophylaxis for the prevention of HIV infection in the United States — 2014: A clinical practice guideline.
        • Arya M.
        • Patel S.
        • Kumar D.
        • Zheng M.Y.
        • Kallen M.A.
        • Street Jr., R.L.
        • et al.
        Why physicians Don't ask: interpersonal and intrapersonal barriers to HIV testing—making a case for a patient-initiated campaign.
        J Int Assoc Provid AIDS Care (JIAPAC). 2016; 15: 306-312
        • Ylitalo K.R.
        • Lee H.
        • Mehta N.K.
        Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey.
        Am J Public Health. 2013; 103: 164-169
        • Gilkey M.B.
        • Calo W.A.
        • Moss J.L.
        • Shah P.D.
        • Marciniak M.W.
        • Brewer N.T.
        Provider communication and HPV vaccination: the impact of recommendation quality.
        Vaccine. 2016; 34: 1187-1192
        • The Washington Post/Kaiser Family Foundation
        2012 Survey of Americans on HIV/AIDS.
        (Retrieved from)
        • Collier K.L.
        • Colarossi L.G.
        • Sanders K.
        A PrEP information and self-screening tool for women.
        AIDS Educ Prev. 2018; 30: 13-25
        • Frost J.J.
        • Gold R.B.
        • Bucek A.
        Specialized FP clinics in the United States: why women choose them and their role in meeting women's health care needs.
        Womens Health Issues. 2012; 22: e519-e525